
Opinion|Videos|April 16, 2024
Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words
Robert Gabbay, MD, PhD, gives closing thoughts and advocates that continuous glucose monitors should be supplied for all insulin-dependent diabetes patients, including at initial diagnosis, to facilitate self-management and tighter control of this disease.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA OKs Zidesamtinib as New Option for Resistant ROS1+ NSCLC
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
4
Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLL
5




